Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Patterson-UTI Energy Inc. Common Stock (PTEN) vs Vir Biotechnology Inc. Common Stock (VIR) Price & Performance

Patterson-UTI Energy Inc. Common StockTrade
Vir Biotechnology Inc. Common StockTrade

Price performance (Past 24H)

Key statistics

Patterson-UTI Energy Inc. Common Stock vs Vir Biotechnology Inc. Common Stock — how do they compare? Patterson-UTI Energy Inc. Common Stock trades at $11.6 (market cap $4.39B), while Vir Biotechnology Inc. Common Stock trades at $10.2 (market cap $1.80B). The key difference: Patterson-UTI Energy Inc. Common Stock is far larger — about 2.4× Vir Biotechnology Inc. Common Stock's market cap, and Patterson-UTI Energy Inc. Common Stock pays a 3.48% dividend while Vir Biotechnology Inc. Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold Patterson-UTI Energy Inc. Common Stock for 3 Days and Vir Biotechnology Inc. Common Stock for 0 Days on average.

PTENVIR
Market Cap
$4.39B$1.80B
Volume
4,811,4961,782,836
Sector
EnergyHealth
52-Week High
$13.15$11.78
52-Week Low
$5.41$5.12
Typical Hold Time
3 Days0 Days
Enterprise Value
$5.47B$1.36B
Dividend Yield
3.48%—

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Patterson-UTI Energy Inc. Common Stock

Patterson-UTI Energy (PTEN) trades at $11.52, up 1.68% today, with a neutral technical signal. The stock shows strong cash flow from operations at $961.22M for 2025, but net income remains negative at -$93.64M. Recent earnings beats and an upcoming Q3 2026 report on October 29, 2026, highlight operational momentum, supported by an average of 103 drilling rigs in September 2026. Analyst consensus is bullish with a $13.38 price target, indicating a 16% upside.

The outlook is cautiously optimistic due to earnings consistency and positive analyst sentiment, but risks include persistent net losses, exposure to oil price volatility, and competitive pressures. Upside potential hinges on sustained rig demand and profitability improvements, while downside risks stem from macroeconomic headwinds affecting energy sectors.

Vir Biotechnology Inc. Common Stock

No Aura AI signal available yet.

Returns comparison

Trailing returns across standard periods

Investor sentiment on Pluang

What Pluang investors did over the last 30 days

PTEN
50% Buy50% Sell
Avg holding period · 3 Days
VIR
51% Buy49% Sell
Avg holding period · 0 Days

About Patterson-UTI Energy Inc. Common Stock

Patterson-UTI Energy provides drilling, completion, and other oilfield services for oil and gas producers in the United States.

Read more on PTEN →

About Vir Biotechnology Inc. Common Stock

Vir Biotechnology, Inc. is a US clinical-stage biopharmaceutical company that develops monoclonal antibody-based medicines to treat and prevent serious infectious diseases.

Read more on VIR →